Bayer Pharmaceuticals

The introduction of new products in the pharmaceuticals industry is characterized by high levels of complexity and high quality standards. Considering the increasing number of new products and types of applications, stable, continuous and efficient processes are a key success factor for the future. In the course of redistributing and consolidating areas of responsibility for the pharmaceuticals division, the product supply organization that was just established a few years ago was restructured and optimized together with UNITY at their site in Basel. 

All Bayer Pharmaceuticals activities were considered in this project, from initial Make or Buy decisions to establishing the supply chain to serial production. The future end-to-end process for product supply was defined cooperatively with all of the areas involved, such as development, product supply, procurement and quality. Roles, responsibilities as well as process steps and respective delivery objects were all continuously defined and almost 100 potentials were identified and unlocked. In addition, measures were derived and fixed into a roadmap in order to increase the organization’s maturity level. The roadmap included the areas of project management and standards, organization and culture as well as management structures and regulations. Detailed project overviews were prepared as a basis for implementation. Furthermore, future best practices were converted into standards systematically and made available to employees for daily use. Thus, transparent and efficient work modes were guaranteed with high quality standards.